IXCELLS BIOTECHNOLOGIES

Company Snapshot

Founded: 2014

Entity Type: Private

Region: U.S.

Headquarter: California, U.S.

Key Geographics: North America

Corporate Address: 10100 Willow Creek Road, San Diego, California 92131, U.S. Tel.: +1-858-412-5988 Web.: www.ixcellsbiotech.com

Company Overview

iXCells Biotechnologies is a cell biology and biotechnology company focused on providing preclinical drug discovery solutions using disease-relevant cellular models for academic, biotechnology, and pharmaceutical companies. It supports research activities in drug discovery, disease modeling, personalized medicine, and regenerative medicine applications. It offers human primary cells, iPSC-derived cells, iPSC cell generation, genome editing, iPSC differentiation, custom cell isolation, antisense oligonucleotide (ASO) screening services, and functional bioassay development services to support translational research and therapeutic development.

IXCELLS BIOTECHNOLOGIES In Reports

Global Peripheral Blood Mononuclear Cells (PBMCs) Market

Analyze the global Peripheral Blood Mononuclear Cells Market by product type, application and technique, covering immunology, oncology, vaccine development and forecasts to 2031.

Global Cell Line and Membrane Market

According to BCC Research Cell Line and Membrane Market report includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through 2030.

Cell Line and Membrane Market

The global cell line and membrane market should reach $220.3 million by 2023 from $172.0 million in 2018 at a compound annual growth rate of 5.1% for the period 2018 to 2023.

View All Reports

IXCELLS BIOTECHNOLOGIES In News

iXCells Biotechnologies reaches iPSC line delivery milestone in collaboration with global biotechnology company - News-Medical

News-Medical - Mar 12, 2026

iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids - businesswire.com

businesswire.com - Mar 24, 2026

iXCells Delivers 500+ Characterized iPSC Lines for Global Biotechnology Company - Contract Pharma

Contract Pharma - Mar 11, 2026

iXCells and Rosebud Biosciences Partner on Organoid-Based Rare Disease Models - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Jan 28, 2026

Read All News

Company's Business Segments

Preclinical Drug Discovery Solutions : The company offers high-quality primary cells, iPSC-derived cells, reagents, and custom pre-clinical drug discovery services.

Applications/End User Industries

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
CROs (Contract Research Organizations) and Toxicology Labs

Life Sciences
Regenerative Medicine & Precision Medicine Firms

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment